Alembic Pharmaceuticals is currently trading at Rs. 420.05, up by 1.15 points or 0.27% from its previous closing of Rs. 418.90 on the BSE.

The scrip opened at Rs. 419.65 and has touched a high and low of Rs. 420.10 and Rs. 417.50 respectively. So far 118 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 588.00 on 15-Feb-2018 and a 52 week low of Rs. 412.40 on 24-May-2018.

Last one week high and low of the scrip stood at Rs. 450.00 and Rs. 417.50 respectively. The current market cap of the company is Rs. 7870.54 crore.

The promoters holding in the company stood at 72.93%, while Institutions and Non-Institutions held 14.32% and 12.75% respectively.

In order to complete existing projects, Alembic Pharmaceuticals has earmarked a capital expenditure of Rs 720 crore for FY19. The company had spent about Rs 600 crore of capex in the last fiscal year.

The pharma firm has filed 12 ANDAs (abbreviated new drug applications) during the March quarter, taking the total filings in FY18 to 26.

The company has six formulation and three API manufacturing facilities. It manufactures general oral solids in Panelav near Vadodara, Gujarat, and is in the process of putting up oncology oral solids and oncology injectable facilities at the same location.

Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×